Yule Chen

1.6k total citations
48 papers, 1.1k citations indexed

About

Yule Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yule Chen has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Yule Chen's work include Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Epigenetics and DNA Methylation (6 papers). Yule Chen is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Epigenetics and DNA Methylation (6 papers). Yule Chen collaborates with scholars based in China, United States and Canada. Yule Chen's co-authors include Dalin He, Jin Zeng, Kaijie Wu, Yang Gao, Jiancheng Zhou, Xinyang Wang, Xinyang Wang, Peng Guo, Shan Xu and Lei Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Yule Chen

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yule Chen China 21 726 281 279 265 109 48 1.1k
Yunguang Tong China 19 796 1.1× 241 0.9× 331 1.2× 145 0.5× 99 0.9× 29 1.4k
Constantin Ștefani Romania 12 673 0.9× 320 1.1× 320 1.1× 222 0.8× 68 0.6× 38 1.2k
Wenbin Song China 19 540 0.7× 245 0.9× 213 0.8× 204 0.8× 85 0.8× 36 985
Xiaodong Xu China 18 645 0.9× 273 1.0× 260 0.9× 157 0.6× 91 0.8× 59 1.2k
Yong Zou China 20 810 1.1× 218 0.8× 390 1.4× 284 1.1× 68 0.6× 48 1.2k
Caiyu Lin China 17 680 0.9× 443 1.6× 262 0.9× 261 1.0× 60 0.6× 43 1.1k
Kuang-Tai Kuo Taiwan 22 544 0.7× 302 1.1× 279 1.0× 218 0.8× 162 1.5× 42 1.1k
Xupeng Bai China 15 874 1.2× 386 1.4× 426 1.5× 180 0.7× 57 0.5× 25 1.4k
Guangchun He China 15 478 0.7× 323 1.1× 297 1.1× 176 0.7× 49 0.4× 25 952

Countries citing papers authored by Yule Chen

Since Specialization
Citations

This map shows the geographic impact of Yule Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yule Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yule Chen more than expected).

Fields of papers citing papers by Yule Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yule Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yule Chen. The network helps show where Yule Chen may publish in the future.

Co-authorship network of co-authors of Yule Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yule Chen. A scholar is included among the top collaborators of Yule Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yule Chen. Yule Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Xinlan, Min Qiang, Rufeng Li, et al.. (2025). Multi-omics profiling reveals downregulated tumor lysine metabolism reshaping the immune microenvironment and therapeutic responses in hepatocellular carcinoma. Journal of Translational Medicine. 23(1). 1117–1117.
2.
Liu, Siqi, Huan Zhang, Yule Chen, Yang Liu, & Chunyue Wang. (2025). Tremella fuciformis Berk alleviates depression by inhibiting NF-κB signaling in mice. Food Bioscience. 68. 106779–106779. 1 indexed citations
3.
Tu, Rongfu, Junpeng Ma, Yule Chen, et al.. (2024). USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression. Cell Death and Disease. 15(10). 749–749. 2 indexed citations
4.
Zhao, Yang, Jiaqi Chen, Tianjie Liu, et al.. (2023). Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS/miR-214-3p/CCL5 pathway. Asian Journal of Andrology. 26(2). 195–204. 7 indexed citations
5.
Xu, Shan, Bohan Ma, Yao Chen, et al.. (2023). EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. Translational Andrology and Urology. 12(1). 71–82. 4 indexed citations
6.
Chen, Yule, et al.. (2022). Serum Metabolomic Patterns in Patients With Aldosterone-Producing Adenoma. Frontiers in Molecular Biosciences. 9. 816469–816469. 5 indexed citations
7.
Jiao, Min, Hui Guo, Yule Chen, Lei Li, & Linlin Zhang. (2020). DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS. Biomedicine & Pharmacotherapy. 128. 110323–110323. 32 indexed citations
8.
Yang, Wenjie, Ke Wang, Jianbin Ma, et al.. (2020). Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression. Archives of Medical Research. 52(2). 174–181. 8 indexed citations
9.
Lv, Wei, Yang Gao, Ke Wang, et al.. (2020). Snail promotes prostate cancer migration by facilitating SPOP ubiquitination and degradation. Biochemical and Biophysical Research Communications. 529(3). 799–804. 10 indexed citations
10.
11.
12.
Wu, Kaijie, Bin Wang, Yule Chen, et al.. (2015). DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling. Cellular Signalling. 27(12). 2515–2523. 29 indexed citations
13.
Zhou, Jiancheng, Kaijie Wu, Guodong Zhu, et al.. (2014). Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 90(4). 942–951. 34 indexed citations
14.
Song, Wenbin, Defeng Xu, Yule Chen, et al.. (2014). Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling. Oncology Reports. 31(3). 1350–1356. 50 indexed citations
15.
Wu, Kaijie, Jin Zeng, Jinhai Fan, et al.. (2013). Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness. Cellular Signalling. 25(12). 2625–2633. 98 indexed citations
16.
Wu, Kaijie, Jinhai Fan, Linlin Zhang, et al.. (2012). PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cellular Signalling. 24(12). 2273–2282. 80 indexed citations
17.
Wu, Kaijie, Jin Zeng, Jiancheng Zhou, et al.. (2012). Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Urologic Oncology Seminars and Original Investigations. 31(8). 1751–1760. 39 indexed citations
18.
Chen, Yule, Lei Li, Jin Zeng, et al.. (2012). Twist Confers Chemoresistance to Anthracyclines in Bladder Cancer through Upregulating P-Glycoprotein. Chemotherapy. 58(4). 264–272. 33 indexed citations
19.
Zeng, Jin, Yi Sun, Kaijie Wu, et al.. (2011). Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria. Molecular Cancer Therapeutics. 10(1). 104–116. 63 indexed citations
20.
Xue, Yan, Lei Li, Dong Zhang, et al.. (2011). Twisted Epithelial-to-Mesenchymal Transition Promotes Progression of Surviving Bladder Cancer T24 Cells with hTERT-Dysfunction. PLoS ONE. 6(11). e27748–e27748. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunguang Tong Breakdown of academic impact, for papers by Constantin Ștefani Breakdown of academic impact, for papers by Wenbin Song Breakdown of academic impact, for papers by Xiaodong Xu Breakdown of academic impact, for papers by Yong Zou Breakdown of academic impact, for papers by Caiyu Lin Breakdown of academic impact, for papers by Kuang-Tai Kuo Breakdown of academic impact, for papers by Xupeng Bai Breakdown of academic impact, for papers by Guangchun He
Rankless by CCL
2026